| Richard Naquin, RPH,LPC,LMFT | |
|
519 Blake Ct, Thibodaux, LA 70301-3503 | |
| (504) 913-8776 | |
| Not Available |
| Full Name | Richard Naquin |
|---|---|
| Gender | Male |
| Speciality | Counselor - Professional |
| Location | 519 Blake Ct, Thibodaux, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659787190 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 10571 (Louisiana) | Secondary |
| 101YP2500X | Counselor - Professional | 2218 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Richard Naquin, RPH,LPC,LMFT 519 Blake Ct, Thibodaux, LA 70301-3503 Ph: (504) 913-8776 | Richard Naquin, RPH,LPC,LMFT 519 Blake Ct, Thibodaux, LA 70301-3503 Ph: (504) 913-8776 |
News Archive
While PCR testing has been used widely for COVID-19 diagnosis, it only provides information on who is currently infected. Antibody testing can tell who has been previously exposed to SARS-CoV-2, the virus that causes COVID-19, a metric that is essential for tracking spread across a population.
Echo Therapeutics, Inc., a company developing the needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, is pleased to announce the availability of an independent research report that was issued yesterday with a "Strong Speculative Buy" recommendation and a 12 to 18 month price target of $4.50.
The Philadelphia region's largest health insurer, Independence Blue Cross, will begin a pay-for-performance model that pays physicians more if their patient's health gets better. The program rewards primary care doctors who provide higher quality care at less cost. "A key element of the program rewards doctors who meet standards as so-called patient-centered medical homes.
Antares Pharma, Inc. today announced that the New Drug Application for OTREXUP, a potential new product for the subcutaneous delivery of methotrexate using Medi-Jet technology, has been accepted by the U.S. Food and Drug Administration indicating that the application is sufficiently complete to permit a substantive review.
The first scientists have moved into the new £650 million Francis Crick Institute building in London and are starting work in their purpose-built labs.
› Verified 4 days ago
Diane Kramarz, Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Abby Rd, Thibodaux, LA 70301 Phone: 985-448-0764 Fax: 985-448-1912 | |
Joshonda Robertson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2528 Talbot Ave, Thibodaux, LA 70301 Phone: 337-579-3379 | |
Shannon White, Counselor Medicare: Not Enrolled in Medicare Practice Location: 102 W 2nd St, Thibodaux, LA 70301 Phone: 985-446-5244 | |
Mrs. Shenee Haas Gros, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 504 Cherry St., Thibodaux, LA 70301 Phone: 985-381-6393 | |
Dr. Chantrelle Deron Varnado-johnson, PHD, LPC-S., NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 906 East 1st Stret, Thibodaux, LA 70310 Phone: 985-448-4349 Fax: 985-448-4435 | |
Mrs. M. Celeste R. Shelby, LPC, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 102 E 5th St, Thibodaux, LA 70301 Phone: 985-447-5383 Fax: 985-447-5384 | |
Ms. Tonya Fay Jones, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1418 Tiger Dr, Thibodaux, LA 70301 Phone: 985-449-4055 |